Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Spina Bifida Occulta 1Neural Tube Defects 1Neoplasms 1Lipomyelomeningocele 1Cerebrospinal Fluid Leak 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Prone Position × Clear all
NCT00887523 2022-12-20

Trial Comparing Prone and Supine Intensity-modulated Radiotherapy (IMRT) After Breast-conserving Surgery in Patients With Large Breast Volume at High Risk for Skin Toxicity and Fibrosis

University Hospital, Ghent

Phase NA Completed
100 enrolled
Breast

Breast Neoplasms

NCT01867268 2015-04-21

Effect of Acetazolamide & Position in CSF Leakage and Collection and Wound Dehiscence

Tehran University of Medical Sciences

Phase 2 Unknown
144 enrolled

Lipomyelomeningocele, Neoplasms, Neural Tube Defects, Spina Bifida Occulta, Cerebrospinal Fluid Leak

NCT00887692 2010-10-19

Comparison of Set-up Reproducibility Between Prone and Supine Intensity Modulated Radiotherapy (IMRT) for the Adjuvant Treatment of Breast Carcinoma After Lumpectomy

University Hospital, Ghent

Phase NA Completed
10 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡